Lansoprazole is superior to ranitidine as maintenance treatment for the prevention of duodenal ulcer relapse

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 6, 1999, Pages 827-832

  Bardhan, K D ^a,g   Crowe, J ^b   Thompson, R P H ^c   Trewby, P N ^d   Keeling, P N ^e   Weir, D ^e   Crouch, S L ^f  

^a Rotherham NHS Foundation Trust   (United Kingdom)

^b MATER PRIVATE HOSPITAL   (Ireland)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d DARLINGTON MEMORIAL HOSPITAL   (United Kingdom)

^e ST JAMES S HOSPITAL   (Ireland)

^f PFIZER INC   (United States)

^g ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; RANITIDINE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; AUSTRALIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DUODENUM ULCER; FEMALE; GASTRITIS; HEADACHE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; VIRUS INFECTION; VOMITING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; DUODENAL ULCER; FEMALE; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; RANITIDINE; RECURRENCE;

EID: 0033037376     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00533.x     Document Type: Article

References (14)

1. 1 Burget DW, Chiverton SG, Hunt R. Is there an optimal degree of acid suppression for healing of duodenal ulcer? Gastroenterology 1990; 99: 345-51.
2. 2 Londong W, Barth H, Damman HG, Hengels KJ. Dose related healing of duodenal ulcer with the proton pump inhibitor lansoprazole. Aliment Pharmacol Ther 1991; 5: 245-54.
3. 3 Licht H, Lemaire M. Lansoprazole versus ranitidine in duodenal ulcer: a French multicentre study. Gastroenterology 1990; 98: A78 (Abstract).
4. 4 Hawkey CJ, Long RG, Bardhan KD, Wormsley KG, Cochran KM, Christian J, Moules IK. Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine. Gut 1993; 34: 1458-62.
5. 5 Hotz J, Kleinart R, Grymbowski T, Hennig U. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration. Aliment Pharmacol Ther 1992; 6: 87-95.
6. 6 McDougle AMA, Lancaster-Smith MJ, Higson DL, Ranitidine maintenance therapy in the prevention of duodenal ulceration: a comparison of 150 mg at night with 300 mg at night. Aliment Pharmacol Ther 1995; 9: 287-91.
7. 7 Tolman KG, Sanders SW, Buchi KN, Karol MD, Jennings DE, Ringham GL. The effects of oral doses of lansoprazole and omeprazole on gastric pH. J Clin Gastroenterol 1997; 24: 65-70.
8. 8 Koch GG, McCanless I, Ward JF. Interpretation of statistical methodology associated with maintenance trials. Am I Med 1984; 77(Suppl. 5B): 43-50.
9. 9 Lee FI, Hardman M, Jaderberg ME. Maintenance treatment of duodenal ulceration: ranitidine 300 mg at night is better than 150 mg in cigarette smokers. Gut 1991; 32: 151-3.
10. 10 Hui WM, Lam SK, Lok ASF, Ng MMT, Lai CL. Maintenance therapy for duodenal ulcer: A randomised controlled comparison of seven forms of treatment. Am J Med 1992; 92: 265-74.
11. 11 Lanza F. Lansoprazole for one year prevents recurrence of duodenal ulcers. Gastroenterology 1994; 106: A122 (Abstract).
12. 12 Hoshino E. Lansoprazole for maintenance therapy of peptic ulcer; weekend full dose or everyday hall dose. Gastroenterology 1995; 108: A117 (Abstract).
13. 13 Karim ON, Logan RPH. The epidemiology of Helicobacter pylori anti-microbial resistance: Preliminary findings of a national survey. Gut 1995; 37(Suppl.2): A6 (Abstract).
14. 14 Glupcyzinskiy, Goutier S, van den Borre C, Butzier JP. Surveillance of Helicobacter pylori resistance to antimicrobial agents in Belgium in 1989 to 1994. Gut 1995; (Suppl.2): A56 (Abstract).